98%
921
2 minutes
20
The placenta is vital to maternal and child health but often overlooked in pregnancy studies. Addressing the need for a more accessible and cost-effective method of placental assessment, our study introduces a computational tool designed for the analysis of placental photographs. Leveraging images and pathology reports collected from sites in the United States and Uganda over a 12-year period, we developed a cross-modal contrastive learning algorithm consisting of pre-alignment, distillation, and retrieval modules. Moreover, the proposed robustness evaluation protocol enables statistical assessment of performance improvements, provides deeper insight into the impact of different features on predictions, and offers practical guidance for its application in a variety of settings. Through extensive experimentation, our tool demonstrates an average area under the receiver operating characteristic curve score of over 82% in both internal and external validations, which underscores the potential of our tool to enhance clinical care across diverse environments.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11701861 | PMC |
http://dx.doi.org/10.1016/j.patter.2024.101097 | DOI Listing |
Neural Netw
September 2025
Shanghai Maritime University, Shanghai, 201306, China. Electronic address:
Cross-modal hashing aims to leverage hashing functions to map multimodal data into a unified low-dimensional space, realizing efficient cross-modal retrieval. In particular, unsupervised cross-modal hashing methods attract significant attention for not needing external label information. However, in the field of unsupervised cross-modal hashing, there are several pressing issues to address: (1) how to facilitate semantic alignment between modalities, and (2) how to effectively capture the intrinsic relationships between data, thereby constructing a more reliable affinity matrix to assist in the learning of hash codes.
View Article and Find Full Text PDFJ Xray Sci Technol
September 2025
Center for Medical Artificial Intelligence, Shandong University of Traditional Chinese Medicine, Qingdao, China.
Parkinson's disease (PD) is a challenging neurodegenerative condition often prone to diagnostic errors, where early and accurate diagnosis is critical for effective clinical management. However, existing diagnostic methods often fail to fully exploit multimodal data or systematically incorporate expert domain knowledge. To address these limitations, we propose MKD-Net, a multimodal and knowledge-driven diagnostic framework that integrates imaging and non-imaging clinical data with structured expert insights to enhance diagnostic performance.
View Article and Find Full Text PDFBioinform Adv
August 2025
IBM Research, Yorktown Heights, NY, 10598, United States.
Motivation: Due to the intricate etiology of neurological disorders, finding interpretable associations between multiomics features can be challenging using standard approaches.
Results: We propose COMICAL, a contrastive learning approach using multiomics data to generate associations between genetic markers and brain imaging-derived phenotypes. COMICAL jointly learns omics representations utilizing transformer-based encoders with custom tokenizers.
Artif Intell Med
August 2025
University of Science and Technology of China, 230000, Hefei, China; Anhui Province Key Laboratory of Biomedical Imaging and Intelligent Processing, Institute of Artificial Intelligence, Hefei Comprehensive National Science Center, Hefei, 230088, China. Electronic address:
The diagnosis of brain tumors is pivotal for effective treatment, with MRI serving as a commonly used non-invasive diagnostic modality in clinical practices. Fundamentally, brain tumor diagnosis is a type of pattern recognition task that requires the integration of information from multi-modal MRI images. However, existing fusion strategies are hindered by the scarcity of multi-modal imaging samples.
View Article and Find Full Text PDFIEEE J Biomed Health Inform
September 2025
The personalization of cancer treatment through drug combinations is critical for improving healthcare outcomes, increasing effectiveness, and reducing side effects. Computational methods have become increasingly important to prioritize synergistic drug pairs because of the vast search space of possible chemicals. However, existing approaches typically rely solely on global molecular structures, neglecting information exchange between different modality representations and interactions between molecular and fine-grained fragments, leading to limited understanding of drug synergy mechanisms for personalized treatment.
View Article and Find Full Text PDF